AI Terminal
Assura PLC
Director's Dealing • Dec 21, 2023
4924_dirs_2023-12-21_164c75d6-38b0-413d-83cb-a943d04bedd8.html
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 6779X
Assura PLC
21 December 2023
21 December 2023
Assura plc
("the Company")
Notification of transaction by Persons Discharging Managerial Responsibilities ("PDMRs") and connected persons
The Company announces the following transactions in respect of Ordinary Shares of 10 pence each in the Company ("Ordinary Shares"):
· Jonathan Murphy's spouse has transferred 252,000 Ordinary Shares into his ISA
· Jonathan Murphy's spouse has transferred 322,000 Ordinary Shares into her ISA
Following the transactions, the total beneficial interest of Jonathan Murphy and his connected persons in the Ordinary Shares is unchanged at 2,944,180.
The Notification of Dealing Forms can be found below.
This notification is made in accordance with the Market Abuse Regulation.
Notification of dealing form
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Jonathan Murphy
2
Reason for the notification
a)
Position/status
CEO
b)
Initial notification/ Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Assura plc
b)
LEI
21380026T19N2Y52XF72
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 10 pence each
GB00BVGBWW93
b)
Nature of the transaction
Transfer of shares from Spouse into his ISA
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £0.4808 GBP | 252,000 |
d)
Aggregated information
- Aggregated volume
- Price
| Aggregate Price | Aggregate Volume | Aggregate Total |
| £0.4808 GBP | 252,000 | £121,161.6 GBP |
e)
Date of the transaction
21/12/2023
f)
Place of the transaction
XLON
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Jonathan Murphy
2
Reason for the notification
a)
Position/status
CEO
b)
Initial notification/ Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Assura plc
b)
LEI
21380026T19N2Y52XF72
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 10 pence each
GB00BVGBWW93
b)
Nature of the transaction
Transfer of shares by Spouse into her ISA
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £0.4808 GBP | 322,000 |
d)
Aggregated information
- Aggregated volume
- Price
| Aggregate Price | Aggregate Volume | Aggregate Total |
| £0.4808 GBP | 322,000 | £154,817.60 GBP |
e)
Date of the transaction
21/12/2023
f)
Place of the transaction
XLON
- Ends -
For further information, please contact:
| Assura plc Orla Ball, Company Secretary David Purcell, Investor Relations Director |
Tel: 0161 515 2043 Email: [email protected] |
| Finsbury Glover Hering Gordon Simpson |
Tel: 0207 251 3801 Email: [email protected] |
Notes to Editors
Assura plc is a national healthcare premises specialist and UK REIT based in Altrincham, UK - caring for more than 600 primary healthcare buildings, from which over six million patients are served.
A constituent of the FTSE 250 and the EPRA* indices, as at 30 September 2023, Assura's portfolio was valued at £2.7 billion.
At Assura, we BUILD for health. Assura builds better spaces for people and places, invests in skills and inspires new ways of working, and unlocks the power of design and innovation to deliver lasting impact for communities - aiming for six million people to have benefitted from improvements to and through its healthcare buildings by 2026.
Assura is leading for a sustainable future, targeting net zero carbon across its portfolio by 2040.
Further information is available at www.assuraplc.com
*EPRA is a registered trademark of the European Public Real Estate Association.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHBLBDDCBDDGXB